Helicobacter pylori infection: Is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients

Canadian Journal of Gastroenterology

Volumn 25, Issue 6, 2011, Pages 315-318

  Urgesi, R ^a,b   Pelecca, G ^a   Cianci, R ^c   Masini, A ^a   Zampaletta, C ^a   Riccioni, M E ^d   Faggiani, R ^a  

^a Digestive Endoscopy Unit   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Institute of Legal Medicine   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Helicobacter pylori; Sequential therapy; Standard therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PANTOPRAZOLE; TINIDAZOLE; UREA C 13; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADULT; ARTICLE; BLOATING; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; ENDOSCOPY; EPIGASTRIC PAIN; ERADICATION THERAPY; GLOSSITIS; HEADACHE; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST; VOMITING; ANTIBIOTIC RESISTANCE; BREATH ANALYSIS; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; FEMALE; GASTROINTESTINAL ENDOSCOPY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PEPTIC ULCER; STANDARD; TOTAL QUALITY MANAGEMENT;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; QUALITY IMPROVEMENT; TREATMENT OUTCOME;

EID: 80052355937     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/967671     Document Type: Article

References (26)

1. Vakil N, Megraud F. Eradication treatment for Helicobacter pylori. Gastroenterology 2007;133:985-1001.
2. Fuccio L, Minardi M, Zagari R, et al. Meta-analysis of first-line proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553-62. (Pubitemid 351664506)
3. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 2007;56:772-81. (Pubitemid 46854190)
4. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycinresistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006;144:94-100. (Pubitemid 46768227)
5. Vakil N, Lanza F, Schwartz H, et al. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004;20:99-107. (Pubitemid 38938723)
6. Cianci R, Montalto M, Pandolfi F, et al. Third-line rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2006;12:2313-9.
7. Zullo A, De Francesco V, Hassan C, et al. The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis. Gut 2007;56:1353-7. (Pubitemid 47517826)
8. 13C-urea. Eur J Gastroenterol Hepatol 1990;2:437-44.
9. 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997;40:459-62.
10. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3:915-8.
11. European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation - World Health Organization. Guideline for Good Clinical Practice. ICH Topic E6. Canary Wharf, UK: EMEA, 2002 〈http://www.emea.europa.eu/pdfs/human/ich/013595en.pdf〉 (Accessed on January 21, 2008).
12. Salako SE. The Declaration of Helsinki 2000: Ethical principles and the dignity of difference. Med Law 2006;25:341-54. (Pubitemid 44202950)
13. Cutler AF, Schubert TT. Patient factors affecting H. pylori eradication with triple therapy. Am J Gastroenterol 1993;88:505-9. (Pubitemid 23106582)
14. Sharma VK, Howden CW. A national survey of primary care physicians' perceptions and practices related to Helicobater pylori infection. J Clin Gastroenterol 2004;38:326-31. (Pubitemid 38393068)
15. Maconi G, Tosetti C, Miroglio G, et al. Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy. Aliment Pharmacol Ther 1999;13:1499-504. (Pubitemid 29516263)
16. Shirin H, Birkenfeld S, Shevah O, et al. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in Israel: Are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol 2004;38:322-5. (Pubitemid 38393067)
17. Laine L, Fennerty MB, Osato M, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenters, double-blind trials. Am J Gastroenterol 2000;95:3393-8.
18. Laheij RJ, Van Rossum LGM, Jansen JB, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection. A meta-analysis. Aliment Pharmacol Ther 1999;13:857-64. (Pubitemid 29312769)
19. Fischbach L, Evans EL. Meta-analysis: Effect of antibiotic resistance on the efficacy of triple and quadruple first-line therapy for Helicobacter pylori. Aliment Pharmacol Ther 2007;1:343-57. (Pubitemid 47063149)
20. Tangmankongworakoon N, Mahachai V, Thong-Ngam D, et al. Pattern of drug resistant Helicobacter pylori in dyspeptic patients in Thailand. J Med Assoc Thai 2003;86(Suppl 2):S439-44. (Pubitemid 37039531)
21. Mahachai V, Thong-Ngam D, Noophun P, et al. Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin resistant strains. J Med Assoc Thai 2006;89(Suppl 3):S74-8.
22. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial. Ann Intern Med 2007;146:556-63. (Pubitemid 351650536)
23. Jafri NS, Hornung CA, Howden CW. Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008;148:923-31. (Pubitemid 351860824)
24. Gatta L, Vakil N, Leandro G, et al. Sequential therapy or triple therapy for Helicobacter pylori: Systematic review and meta-analysis of randomized controlled trials in adult and children. Am J Gastroenterol 2009;104:3069-79.
25. Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: A meta-analysis. J Clin Pharm Ther 2009;34:41-53.
26. Sisson G, Goodwin A, Raudonikiene A, et al. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 2002;46:2116-23. (Pubitemid 34665905)